Mild lipid stress induces profound loss of MC4R protein abundance and function

Molecular Endocrinology

Volumn 28, Issue 3, 2014, Pages 357-367

  Cragle, Faith K ^a   Baldini, Giulia ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHENYLBUTYRIC ACID; ALPHA INTERMEDIN; CASPASE 3; CELL PROTEIN; CHAPERONE; CYCLIC AMP; LIPID; MELANOCORTIN 4 RECEPTOR; PALMITIC ACID; X BOX BINDING PROTEIN 1;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL ELECTROPHORESIS; HYPOTHALAMUS; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; LIPID DIET; LIPID STRESS; NERVE CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ALPHA-MSH; ANIMALS; CELL LINE; DYSLIPIDEMIAS; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION; HYPOTHALAMUS; MICE; NEURONS; PALMITATES; RECEPTOR, MELANOCORTIN, TYPE 4; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE;

EID: 84896862470     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2013-1357     Document Type: Article

References (62)

1. Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb. 2010; 17 (4): 332-341.
2. Cascio G, Schiera G, Di Liegro I. Dietary fatty acids in metabolic syndrome, diabetes and cardiovascular diseases. Curr Diabetes Rev. 2012; 8 (1): 2-17.
3. Lottenberg AM, Afonso MdS, Lavrador MSF, Machado RM, Nakandakare ER. The role of dietary fatty acids in the pathology of metabolic syndrome. J Nutr Biochem. 2012; 23 (9): 1027-1040.
4. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature. 2006; 443 (7109): 289-295.
5. Cone RD. Studies on the physiological functions of the melanocortin system. Endocr Rev. 2006; 27 (7): 736-749.
6. Williams KW, Elmquist JK. From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior. Nat Neurosci. 2012; 15 (10): 1350-1355.
7. Enriori PJ, Evans AE, Sinnayah P, et al. Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab. 2007; 5 (3): 181-194.
8. De Souza CT, Araujo EP, Bordin S, et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology. 2005; 146 (10): 4192-4199.
9. Milanski M, Degasperi G, Coope A, et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci. 2009; 29 (2): 359-370.
10. Ozcan L, Ergin AS, Lu A, et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 2009; 9 (1): 35-51.
11. Thaler JP, Yi C-X, Schur EA, et al. Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest. 2012; 122 (1): 153-162.
12. Benoit SC, Kemp CJ, Elias CF, et al. Palmitic acid mediates hypothalamic insulin resistance by altering PKC-θ subcellular localization in rodents. J Clin Invest. 2009; 119 (9): 2577-2589.
13. Clegg DJ, Benoit SC, Reed JA, Woods SC, Dunn-Meynell A, Levin BE. Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet. Am J Physiol Regul Integr Comp Physiol. 2005; 288 (4): R981-R986.
14. Clegg DJ, Gotoh K, Kemp C, et al. Consumption of a high-fat diet induces central insulin resistance independent of adiposity. Physiol Behav. 2011; 103 (1): 10-16.
15. Munzberg H, Flier JS, Bjorbaek C. Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology. 2004; 145 (11): 4880-4889.
16. Stofkova A, Skurlova M, Kiss A, Zelezna B, Zorad S, Jurcovicova J. Activation of hypothalamic NPY, AgRP, MC4R, ANDIL-6mRNA levels in young Lewis rats with early-life diet-induced obesity. Endocr Regul. 2009; 43 (3): 99-106.
17. Gutierrez-Aguilar R, Kim D-H, Woods SC, Seeley RJ. Expression of new loci associated with obesity in diet-induced obese rats: from genetics to physiology. Obesity (Silver Spring, Md). 2012; 20 (2): 306-312.
18. Chen H, Simar D, Morris MJ. Hypothalamic neuroendocrine circuitry is programmed by maternal obesity: interaction with postnatal nutritional environment. PloS One. 2009; 4 (7): e6259.
19. Woods SC, D'Alessio DA, Tso P, et al. Consumption of a high-fat diet alters the homeostatic regulation of energy balance. Physiol Behav. 2004; 83 (4): 573-578.
20. Clegg DJ, Benoit SC, Air EL, et al. Increased dietary fat attenuates the anorexic effects of intracerebroventricular injections of MTII. Endocrinology. 2003; 144 (7): 2941-2946.
21. Irani BG, Dunn-Meynell AA, Levin BE. Altered hypothalamic leptin, insulin, and melanocortin binding associated with moderate-fat diet and predisposition to obesity. Endocrinology. 2007; 148 (1): 310-316.
22. Krishna R, Gumbiner B, Stevens C, et al. Potent and selective agonism of the melanocortin receptor 4 with MK-0493 does not induce weight loss in obese human subjects: energy intake predicts lack of weight loss efficacy. Clin Pharmacol Ther. 2009; 86 (6): 659-666.
23. Shojaee-Moradie F, Baynes KCR, Pentecost C, et al. Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism. Diabetologia. 2007; 50 (2): 404-413.
24. Sabin MA, De Hora M, Holly JMP, et al. Fasting nonesterified fatty acid profiles in childhood and their relationship with adiposity, insulin sensitivity, and lipid levels. Pediatrics. 2007; 120 (6): e1426-e1433.
25. Posey KA, Clegg DJ, Printz RL, et al. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am J Physiol Endocrinol Metab. 2009; 296 (5): E1003-E1012.
26. Peyot M-L, Pepin E, Lamontagne J, et al. β-Cell failure in dietinduced obese mice stratified according to body weight gain: secretory dysfunction and altered islet lipid metabolism without steatosis or reduced beta-cell mass. Diabetes. 2010; 59 (9): 2178-2187.
27. Mayer CM, Belsham DD. Palmitate attenuates insulin signaling and induces endoplasmic reticulum stress and apoptosis in hypothalamic neurons: rescue of resistance and apoptosis through adenosine 5' monophosphate-activated protein kinase activation. Endocrinology. 2010; 151 (2): 576-585.
28. Choi SJ, Kim F, Schwartz MW, Wisse BE. Cultured hypothalamic neurons are resistant to inflammation and insulin resistance induced by saturated fatty acids. Am J Physiol Endocrinol Metab. 2010; 298 (6): E1122-E1130.
29. Mohammad S, Baldini G, Granell S, Narducci P, Martelli AM, Baldini G. Constitutive traffic of melanocortin-4 receptor in Neuro2A cells and immortalized hypothalamic neurons. J Biol Chem. 2007; 282 (7): 4963-4974.
30. Granell S, Mohammad S, Ramanagoudr-Bhojappa R, Baldini G. Obesity-linked variants of melanocortin-4 receptor are misfolded in the endoplasmic reticulum and can be rescued to the cell surface by a chemical chaperone. Mol Endocrinol. 2010; 24 (9): 1805-1821.
31. Granell S, Serra-Juhe C, Martos-Moreno GA, et al. A novel melanocortin-4 receptor mutation MC4R-P272L associated with severe obesity has increased propensity to be ubiquitinated in the ER in the face of correct folding. PloS One. 2012; 7 (12): e50894.
32. Tao Y-X. The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr Rev. 2010; 31 (4): 506-543.
33. Titolo D, Cai F, Belsham DD. Coordinate regulation of neuropeptide Y and agouti-related peptide gene expression by estrogen depends on the ratio of estrogen receptor (ER) α to ERβ in clonal hypothalamic neurons. Mol Endocrinol. 2006; 20 (9): 2080-2092.
34. Mayer CM, Fick LJ, Gingerich S, Belsham DD. Hypothalamic cell lines to investigate neuroendocrine control mechanisms. Front Neuroendocrinol. 2009; 30 (3): 405-423.
35. Serlie MJ, Meijer AJ, Groener JE, et al. Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects. J Clin Endocrinol Metab. 2007; 92 (4): 1524-1529.
36. Shinyama H, Masuzaki H, Fang H, Flier JS. Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization. Endocrinology. 2003; 144 (4): 1301-1314.
37. Granell S, Molden BM, Baldini G. Exposure of MC4R to agonist in the endoplasmic reticulum stabilizes an active conformation of the receptor that does not desensitize. Proc Natl Acad Sci USA. 2013; 110 (49): E4733-E4742.
38. McDaniel FK, Molden BM, Mohammad S, et al. Constitutive cholesterol-dependent endocytosis of melanocortin-4 receptor (MC4R) is essential to maintain receptor responsiveness to α-melanocytestimulating hormone (α-MSH). J Biol Chem. 2012; 287 (26): 21873-21890.
39. Wang S, Kaufman RJ. The impact of the unfolded protein response on human disease. J Cell Biol. 2012; 197 (7): 857-867.
40. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell. 2001; 107 (7): 881-891.
41. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 2007; 8 (7): 519-529.
42. Fu S, Watkins SM, Hotamisligil GS. The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling. Cell Metab. 2012; 15 (5): 623-634.
43. Zeng L, Lu M, Mori K, et al. ATF6 modulates SREBP2-mediated lipogenesis. EMBO J. 2004; 23 (4): 950-958.
44. Brown MS, Goldstein JL. Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL. J Lipid Res. 2009; 50 (suppl): S15-S27.
45. Ozcan U, Yilmaz E, Ozcan L, et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 2006; 313 (5790): 1137-1140.
46. Xiao C, Giacca A, Lewis GF. Sodium phenylbutyrate, a drug with known capacity to reduce endoplasmic reticulum stress, partially alleviates lipid-induced insulin resistance and β-cell dysfunction in humans. Diabetes. 2011; 60 (3): 918-924.
47. de Almeida SF, Picarote G, Fleming JV, Carmo-Fonseca M, Azevedo JE, de Sousa M. Chemical chaperones reduce endoplasmic reticulum stress and prevent mutant HFE aggregate formation. J Biol Chem. 2007; 282 (38): 27905-27912.
48. Rubenstein RC, Egan ME, Zeitlin PL. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR. J Clin Invest. 1997; 100 (10): 2457-2465.
49. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med. 2003; 348 (12): 1085-1095.
50. Yeo GS, Lank EJ, Farooqi IS, Keogh J, Challis BG, O'Rahilly S. Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms. Hum Mol Genet. 2003; 12 (5): 561-574.
51. Lubrano-Berthelier C, Durand E, Dubern B, et al. Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. Hum Mol Genet. 2003; 12 (2): 145-153.
52. Nijenhuis WA, Garner KM, van Rozen RJ, Adan RA. Poor cell surface expression of human melanocortin-4 receptor mutations associated with obesity. J Biol Chem. 2003; 278 (25): 22939-22945.
53. Tao YX, Segaloff DL. Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity. Endocrinology. 2003; 144 (10): 4544-4551.
54. Moraes JC, Coope A, Morari J, et al. High-fat diet induces apoptosis of hypothalamic neurons. PloS One. 2009; 4 (4): e5045.
55. Pierroz DD, Ziotopoulou M, Ungsunan L, Moschos S, Flier JS, Mantzoros CS. Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. Diabetes. 2002; 51 (5): 1337-1345.
56. Bluher S, Ziotopoulou M, Bullen JW Jr, et al. Responsiveness to peripherally administered melanocortins in lean and obese mice. Diabetes. 2004; 53 (1): 82-90.
57. Suzuki R, Lee K, Jing E, et al. Diabetes and insulin in regulation of brain cholesterol metabolism. Cell Metab. 2010; 12 (6): 567-579.
58. Borg ML, Omran SF, Weir J, Meikle PJ, Watt MJ. Consumption of a high-fat diet, but not regular endurance exercise training, regulates hypothalamic lipid accumulation in mice. J Physiol. 2012; 590 (Pt 17): 4377-4389.
59. Fu S, Yang L, Li P, et al. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature. 2011; 473 (7348): 528-531.
60. Tokhtaeva E, Sachs G, Vagin O. Assembly with the Na, K-ATPase α (1) subunit is required for export of β (1) and β (2) subunits from the endoplasmic reticulum. Biochemistry. 2009; 48 (48): 11421-11431.
61. Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012; 15 (5): 635-645.
62. Yue JTY, Lam TKT. Lipid sensing and insulin resistance in the brain. Cell Metab. 2012; 15 (5): 646-655.